About this document
Drug Patents and Generic Competition Insights by rimjhim pandey is a document available to read on EtoBox.
The document examines the relationship between drug patents, regulatory exclusivities, and generic competition, revealing that a majority of approved drug products lack patent protection. It highlights that generic drug approvals can occur even with existing patents and that the expiration of patents does not guarantee subsequent generic entry or significant price reductions. The authors argue for a broader understanding of factors influencing drug prices beyond patents and exclusivities, suggesting that po
- Author
- rimjhim pandey
- Language
- EN